✦ LIBER ✦

Parametrial implant in stage III B cancer of the cervix III. A five-year study

✍ Scribed by Thongbliew Prempree

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 287 KB
Volume: 52
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19830815)52:4<748::aid-cncr2820520431>3.0.co;2-o

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levamisole in the treatment of stage II

Levamisole in the treatment of stage II breast cancer five-year follow-up of a randomized double-blind study

✍ Pentti Klefström; Paul Holsti; Pentti Gröhn; Erkki Heinonen; Lars Holsti 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB 👁 3 views

Sole brachytherapy of the tumor bed afte

Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five-year results of a phase I–II study and initial findings of a randomized phase III trial

✍ Csaba Polgár; Zoltán Sulyok; János Fodor; Zsolt Orosz; Tibor Major; Zoltán Takác 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 1 views

Randomised clinical trial of adjuvant po

Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II–III resectable rectal cancer: A final report

✍ Ferdinando Cafiero; Marco Gipponi; Rita Lionetto; the P.A.R. Cooperative Study G 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

A phase 3 randomized controlled trial of

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer

✍ Michael A. Carducci; Fred Saad; Per-Anders Abrahamsson; David P. Dearnaley; Clau 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to evaluate the efficacy and safety of atrasentan (Xinlay), a selective endothelin‐A receptor antagonist, in patients with metastatic hormone‐refractory prostate cancer (HRPC). ## METHODS. This multinational, double‐blind, placebo‐contro

Risedronate decreases biochemical marker

Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: Results of the two-year multinational knee osteoarthritis structural arthritis study

✍ Clifton O. Bingham III; J. Chris Buckland-Wright; Patrick Garnero; Stanley B. Co 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB 👁 2 views

## Abstract ## Objective Bisphosphonates have slowed the progression of osteoarthritis (OA) in animal models and have decreased pain in states of high bone turnover. The Knee OA Structural Arthritis (KOSTAR) study, which is the largest study to date investigating a potential structure‐modifying OA